MENLO PARK, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on December 19, 2025 to all common stockholders of record as of December 5, 2025. Exponent has paid, and expects to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are sub ...

Company delivers 99th consecutive quarter of topline growthThird quarter 2025 revenue grew 16% and recurring revenue grew 18% from the third quarter of 2024Appoints new Chief Commercial Officer as longtime Chief Revenue Officer intends to retireAnnounces new Share Repurchase Program MINNEAPOLIS, Oct. 30, 2025 (GLOBE NEWSWIRE) -- SPS Commerce, Inc. (NASDAQ: SPSC), a leader in retail supply chain cloud services, today announced financial results for the third quarter ended September 30, 2025. Financial Highli ...

Conference Call Scheduled for Thursday, November 13, 2025 at 4:30 pm ETSARATOGA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- CapsoVision, Inc. (NASDAQ: CV), a commercial-stage medical technology company developing advanced imaging and AI-enabled capsule endoscopy solutions, today announced that the company will release third quarter 2025 financial results on Thursday, November 13, 2025, after the close of market. CapsoVision will host a corresponding conference call and a live webcast at 1:30 pm PT / 4:30 pm ...

Raises Full-year GuidanceCHARLOTTE, N.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- SPX Technologies, Inc. (NYSE:SPXC) (“SPX”, the “Company”, “we” or “our”) today reported results for the third quarter ended September 27, 2025. Third Quarter Highlights (amounts presented for continuing operations; all comparisons against the third quarter of 2024, unless otherwise noted) Revenue of $592.8 million, up 22.6%GAAP income from continuing operations of $63.1 million, up 24.0%GAAP EPS of $1.29, up 19.4%Adjusted EPS* of $1 ...

Core Insights - Stryker Corporation reported strong financial performance for Q3 2025, with net sales of $6.1 billion, reflecting a 10.3% increase compared to the previous year [2][13]. - The company achieved double-digit adjusted earnings per share growth, with adjusted net earnings of $1.2 billion, up 11.4% year-over-year [4][13]. - Stryker raised its full-year 2025 guidance, expecting organic net sales growth of 9.8% to 10.2% and adjusted net earnings per diluted share in the range of $13.50 to $13.60 [5][6]. Sales Performance - Consolidated net sales increased by 10.3% in Q3 2025, with organic net sales growing by 9.5%, driven by a 9.1% increase in unit volume and a 0.4% rise in prices [2][13]. - MedSurg and Neurotechnology segment reported net sales of $3.8 billion, a 14.4% increase, while Orthopaedics segment net sales reached $2.3 billion, up 3.9% [2][3]. Earnings Analysis - Reported net earnings for the quarter were $859 million, a 3.0% increase, with diluted earnings per share rising to $2.22, up 2.8% [4][13]. - Adjusted gross profit margin was 65.0%, and adjusted operating income margin increased to 25.6% [4][13]. Outlook - The company anticipates continued sales momentum and sustained demand for its products, leading to an optimistic outlook for the remainder of 2025 [5][6]. - A modestly favorable pricing impact and slight positive effects from foreign exchange rates are expected to contribute to sales and earnings growth [6]. Segment Performance - The MedSurg and Neurotechnology segment saw organic net sales growth of 8.4%, while Orthopaedics experienced a significant organic growth of 11.4% when excluding the divested spinal implant business [3][4]. - The U.S. market contributed significantly to sales, with a reported growth of 11.4% in Q3 2025 [24]. Financial Position - Total assets as of September 30, 2025, were $47.1 billion, an increase from $43.0 billion at the end of 2024 [19][20]. - The company reported a net cash provided by operating activities of $2.9 billion for the nine months ended September 30, 2025 [22].

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies, today announced that the company will report third quarter 2025 financial results on Thursday, November 13, 2025. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates. Title: Cibus, Inc. Third Quarter 2025 Results Conference Call Event ...

Webcast Scheduled for Thursday, November 6 at 4:30 p.m. EasternCHASKA, Minn., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the three months ended September 30, 2025, on Thursday, November 6, 2025, after market close. At 4:30 p.m. Eastern Time that day, members of Lifecore’s senior management team will host a webcast to discuss ...

Highlights: GAAP diluted earnings per share (EPS) of $0.47 for the third quarterThird quarter revenue of $934 millionNon-GAAP adjusted EPS of $0.49, which excludes adjusted items in the quarter Operating income of $39 million or 4.2% of revenue, adjusted operating income (non-GAAP) of $41 million or 4.4% of revenue Closed on the acquisitions of Marten Transport Intermodal assets and SITH, LLCStrong balance sheet with net debt/EBITDA LTM (non-GAAP) of 0.4x as of September 30, 2025 OAK BROOK, Ill., Oct. 30, ...

Key Financial Results - The company reported a net loss of $30 million, translating to a diluted loss per share of $0.37, compared to a net income of $255 million or $3.39 per share in Q3 2024 [5][8] - Adjusted EPS increased by 25% year-over-year to $5.20 [5] - Gross profit rose by 31% year-over-year to $1,479 million [5] - Core G&A expenses increased by 33% year-over-year to $477 million [5] - Adjusted pre-tax income increased by 35% year-over-year to $569 million [5] - Total advisory and brokerage assets increased by 45% year-over-year to $2.3 trillion [5] Key Business Results - Total net new assets were $308 billion, including $275 billion from the acquisition of Commonwealth [5] - Organic net new assets were $33 billion, representing a 7% annualized growth [5] - Recruited assets were $33 billion, up 27% from a year ago [5] - Client cash balances increased to $56 billion, up $10 billion year-over-year [5] Key Capital and Liquidity Measures - The company onboarded First Horizon with $18 billion of brokerage and advisory assets, of which $17 billion transitioned onto the platform in Q3 [3] - Corporate cash stood at $568 million, with a leverage ratio of 2.04x [5] - The company declared a dividend of $0.30 per share to be paid on December 1, 2025 [10] M&A - The acquisition of Commonwealth was closed, with an expected conversion completion in Q4 2026 [6] - The estimated run-rate EBITDA for Commonwealth increased from $415 million to $425 million [6] - The company is tracking towards a 90% retention target for Commonwealth advisors, with nearly 80% of assets signed to date [6]

Core Points - Zoom Communications, Inc. will release its financial results for Q3 of fiscal year 2026 on November 24, 2025, after market close [1] - A live webinar for the financial results will be accessible at 2:00 pm PT / 5:00 pm ET through Zoom's investor relations website [1] Company Overview - Zoom provides an AI-first, open work platform designed for human connection, facilitating seamless collaboration across various communication methods including meetings, chat, and phone [2] - The company was founded in 2011 and is headquartered in San Jose, CA [2]